Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2025)

Ascend Wellness Holdings (AAWH) has 6 years of Cash from Financing Activities data on record, last reported at $6.5 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 170.61% year-over-year to $6.5 million; the TTM value through Sep 2025 reached $1.3 million, up 108.21%, while the annual FY2024 figure was -$20.3 million, 19.13% down from the prior year.
  • Cash from Financing Activities reached $6.5 million in Q3 2025 per AAWH's latest filing, up from -$14.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $124.9 million in Q3 2021 and bottomed at -$14.0 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $15.4 million, with a median of -$949000.0 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: soared 3068.31% in 2021, then tumbled 6947.95% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.9 million in 2021, then surged by 1070.0% to $18.5 million in 2022, then tumbled by 99.61% to $73000.0 in 2023, then crashed by 6947.95% to -$5.0 million in 2024, then surged by 230.87% to $6.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $6.5 million in Q3 2025, -$14.0 million in Q2 2025, and $13.7 million in Q1 2025.